US2023111666A1PendingUtilityA1

Therapeutic delivery vesicles

Assignee: EVOX THERAPEUTICS LTDPriority: Apr 12, 2013Filed: Dec 12, 2022Published: Apr 13, 2023
Est. expiryApr 12, 2033(~6.7 yrs left)· nominal 20-yr term from priority
A61K 38/177A61P 17/06A61P 21/00A61P 25/00A61K 38/00A61K 47/6911A61K 9/00A61P 11/00F01C 1/3442A61P 13/12F01C 21/102A61P 31/00A61K 47/62A61P 35/00A61P 37/02A61P 29/00C07K 14/70596C07K 2319/00A61P 19/02A61P 1/14A61P 15/00A61P 3/10A61P 1/04C07K 14/705A61P 1/16C07K 14/70578A61P 17/00A61P 9/00A61P 9/10
68
PatentIndex Score
0
Cited by
0
References
0
Claims

Abstract

The present invention pertains to inter alia methods for purifying extracellular vesicles including exposing a sample comprising at least one extracellular vesicle to ultrafiltration; and exposing the sample following the ultrafiltration in step (i) to size exclusion liquid chromatography.

Claims

exact text as granted — not AI-modified
What is claimed is: 
     
         1 . A method for purifying extracellular vesicles comprising:
 (i) exposing a sample comprising at least one extracellular vesicle to ultrafiltration; and   (ii) exposing the sample following the ultrafiltration in step (i) to size exclusion liquid chromatography.   
     
     
         2 . A method of  claim 1 , wherein at least one filter is used during ultrafiltration. 
     
     
         3 . A method of  claim 2 , wherein the at least one filter comprises a molecular weight cut-off of 100 kDa. 
     
     
         4 . A method of  claim 2 , wherein the at least one filter comprises a molecular weight cut-off of 200 kDa. 
     
     
         5 . A method of  claim 2 , wherein the at least one filter comprises a molecular weight cut-off of 500 kDa. 
     
     
         6 . A method of  claim 1 , wherein at least two different filters are used during ultrafiltration and wherein the at least two different filters have the same molecular weight cut-off. 
     
     
         7 . A method of  claim 1 , wherein at least two different filters are used during ultrafiltration and wherein the at least two different filters have a different molecular weight cut-off. 
     
     
         8 . A method of  claim 1 , further comprising prior to step (i) exposing the sample to stress-inducing conditions. 
     
     
         9 . A method of  claim 8 , wherein the stress-inducing conditions are oxygen deprivation, serum starvation, or a combination thereof. 
     
     
         10 . A method of  claim 1 , further comprising prior to step (i) exposing the sample to autophagy-inhibiting substances. 
     
     
         11 . A method of  claim 1 , wherein the extracellular vesicles purified using ultrafiltration followed by size exclusion liquid chromatography comprise less protein contamination than extracellular vesicles purified using ultrafiltration alone. 
     
     
         12 . A method of  claim 1 , wherein the extracellular vesicles purified using ultrafiltration followed by size exclusion liquid chromatography comprise less vesicle distortion and improved vesicle integrity than extracellular vesicles purified using ultrafiltration alone. 
     
     
         13 . A method for purifying extracellular vesicles, comprising:
 (i) introducing at least one polynucleotide construct encoding at least one polypeptide into a cell capable of producing extracellular vesicles;   (ii) collecting the extracellular vesicles produced by the cell of step (i); and   (iii) purifying the extracellular vesicles collected in step (ii) using ultrafiltration followed by size exclusion liquid chromatography.   
     
     
         14 . A method of  claim 13 , wherein at least one filter is used during ultrafiltration. 
     
     
         15 . A method of  claim 14 , wherein the at least one filter comprises a molecular weight cut-off of 100 kDa. 
     
     
         16 . A method of  claim 14 , wherein the at least one filter comprises a molecular weight cut-off of 200 kDa. 
     
     
         17 . A method of  claim 14 , wherein the at least one filter comprises a molecular weight cut-off of 500 kDa. 
     
     
         18 . A method of  claim 13 , wherein at least two different filters are used during ultrafiltration and wherein the at least two different filters have the same molecular weight cut-off. 
     
     
         19 . A method of  claim 13 , wherein at least two different filters are used during ultrafiltration and wherein the at least two different filters have a different molecular weight cut-off. 
     
     
         20 . A method of  claim 13 , further comprising prior to step (ii) exposing the cell to stress-inducing conditions. 
     
     
         21 . A method of  claim 20 , wherein the stress-inducing conditions are oxygen deprivation, serum starvation, or a combination thereof. 
     
     
         22 . A method of  claim 13 , further comprising prior to step (ii) exposing the cell to autophagy-inhibiting substances. 
     
     
         23 . A method of  claim 13 , wherein the extracellular vesicles purified using ultrafiltration followed by size exclusion liquid chromatography comprise less protein contamination than extracellular vesicles purified using ultrafiltration alone. 
     
     
         24 . A method of  claim 13 , wherein the extracellular vesicles purified using ultrafiltration followed by size exclusion liquid chromatography comprise less vesicle distortion and improved vesicle integrity than extracellular vesicles purified using ultrafiltration alone.

Join the waitlist — get patent alerts

Track US2023111666A1 — get alerts on status changes and closely related new filings.

We store only your email — no account needed. See our privacy policy.